ABT vs SYK
ABT and SYK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABTABBOTT LABORATORIES | SYKSTRYKER CORP |
|---|---|---|
| Market cap | $190.69B | $114.19B |
| P/E (TTM) | 30.7 | 31.9 |
| P/B | 3.66 | 9.73 |
| P/S | 4.3x | 4.5x |
| Dividend yield | 2.16% | 1.12% |
| Revenue | $45.13B(TTM) | $26.30B(TTM) |
| Revenue growth (YoY) | 5.7% | 11.2% |
| Net income | $6.28B(TTM) | $3.62B(TTM) |
| Earnings growth (YoY) | -51.3% | 8.5% |
| EPS, diluted | $3.57(TTM) | $9.39(TTM) |
| EBIT margin | 18.2% | 19.5% |
| ROE | 12.5% | 27.7% |
| ROIC | 8.3% | 15.0% |
| Piotroski F | — | 9/9 |
| 1y total return | -10.0% | -15.5% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: ABT frente a SYK
| Métrica | ABT | SYK |
|---|---|---|
| Valor final | $34.0K | $28.0K |
| Retorno total | +240.3% | +179.5% |
| CAGR | +12.6% | +10.4% |
| Volatilidad | 23.9% | 26.9% |
| Sharpe | 0.44 | 0.35 |
| Sortino | 0.63 | 0.50 |
| Caída máxima | -39.6% | -43.8% |
Basado en 2600 días de negociación comunes, 2016-06-30 → 2026-11-02 · tasa libre de riesgo 4.16% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)